This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: 10X Genomics, Inc.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Michael Stubbington: Innovator in Macromolecule Labeling and Antigen Screening
Introduction
Michael Stubbington is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of polynucleotide processing and analyte characterization. With a total of 2 patents, his work focuses on advancing methods and systems that enhance the understanding of macromolecules and antigens.
Latest Patents
Stubbington's latest patents include "Methods and systems for macromolecule labeling" and "Methods and systems for antigen screening." The first patent provides compositions, methods, systems, and devices for polynucleotide processing and analyte characterization from one or more cells. This innovation is particularly useful for generating labeled macromolecules, including major histocompatibility complex (MHC) molecules and dextramers. The process involves in vitro transcription reactions and can occur in one or more partitions. The second patent focuses on polynucleotide processing and antigen screening, utilizing engineered cells to characterize various analytes, including polypeptide antigens.
Career Highlights
Michael Stubbington is currently employed at 10x Genomics, Inc., where he continues to push the boundaries of scientific research and innovation. His work has been instrumental in developing new technologies that have the potential to impact various applications in biotechnology and medicine.
Collaborations
Stubbington collaborates with talented individuals such as Katherine Pfeiffer and Sarah Taylor, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Michael Stubbington's contributions to the fields of macromolecule labeling and antigen screening exemplify the importance of innovation in scientific research. His patents reflect a commitment to advancing technology that can lead to significant breakthroughs in understanding complex biological systems.